Guhan Pharmaceutical Group Co., Ltd. (SHE:000590)
China · Delayed Price · Currency is CNY 8.02
-0.06 (-0.74%)
Jul 30, 2026, 3:04 PM CST
SHE:000590 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 1,921 | 2,684 | 1,703 | 2,146 | 2,141 | 2,366 | |
Market Cap Growth | -33.88% | 57.66% | -20.65% | 0.22% | -9.51% | 16.51% |
Enterprise Value | 1,847 | 2,606 | 1,625 | 2,045 | 1,954 | 2,022 |
Last Close Price | 8.02 | 11.21 | 7.11 | 8.96 | 8.94 | 9.88 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 84.99 | 118.22 | 66.76 |
Forward PE | - | 91.43 | 91.43 | 91.43 | 91.43 | 91.43 |
PS Ratio | 5.58 | 7.95 | 4.96 | 5.30 | 6.11 | 7.87 |
PB Ratio | 3.54 | 4.89 | 2.83 | 2.95 | 3.05 | 3.47 |
P/TBV Ratio | 4.59 | 6.33 | 3.75 | 4.67 | 5.30 | 4.33 |
P/FCF Ratio | 227.34 | - | - | - | 59.82 | - |
P/OCF Ratio | 32.60 | 92.71 | 97.92 | - | 39.30 | 93.90 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 5.37 | 7.72 | 4.74 | 5.05 | 5.57 | 6.72 |
EV/EBITDA Ratio | 126.93 | 833.68 | 2608.91 | 51.76 | 58.25 | 47.48 |
EV/EBIT Ratio | - | - | - | 143.00 | 161.08 | 78.18 |
EV/FCF Ratio | 218.63 | - | - | - | 54.59 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.13 | 0.13 | 0.16 | 0.13 | 0.19 | 0.01 |
Debt / EBITDA Ratio | 4.95 | 12.18 | 28.04 | 2.25 | 3.67 | 0.19 |
Debt / FCF Ratio | 8.53 | - | - | - | 3.74 | - |
Net Debt / Equity Ratio | -0.14 | -0.19 | -0.13 | -0.13 | -0.18 | -0.46 |
Net Debt / EBITDA Ratio | -6.39 | -33.82 | -126.60 | -2.39 | -3.78 | -7.45 |
Net Debt / FCF Ratio | -8.90 | 5.33 | 5.36 | 1.83 | -3.54 | 467.03 |
Asset Turnover | 0.36 | 0.36 | 0.32 | 0.35 | 0.33 | 0.32 |
Inventory Turnover | - | 1.61 | 1.44 | 1.56 | 1.68 | 1.96 |
Quick Ratio | 1.19 | 1.31 | 1.57 | 1.63 | 1.50 | 2.44 |
Current Ratio | 1.88 | 1.88 | 2.12 | 2.17 | 1.95 | 2.96 |
Return on Equity (ROE) | -7.21% | -8.70% | -19.14% | 3.48% | 2.62% | 5.34% |
Return on Assets (ROA) | -1.16% | -1.68% | -1.48% | 0.77% | 0.71% | 1.74% |
Return on Invested Capital (ROIC) | -3.86% | -5.31% | -4.45% | 1.98% | 2.14% | 6.52% |
Return on Capital Employed (ROCE) | -2.60% | -3.70% | -3.30% | 1.60% | 1.40% | 3.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -2.14% | -1.88% | -7.37% | 1.18% | 0.85% | 1.50% |
FCF Yield | 0.44% | -0.74% | -0.86% | -2.40% | 1.67% | -0.03% |
Payout Ratio | - | - | - | 16.62% | 1.87% | 0.18% |